Cobro Ventures

Cobro Ventures

Cobro Ventures

Suggest edits
Follow us
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 7

Portfolio

Portfolio Tracker

Add info
Pulse 2.0

C4 Therapeutics (CCCC) Stock: $15 Price Target From BofA

C4 Therapeutics
C4 Therapeutics
Forbes

Dyslexic To Disruptor: Frequency Therapeutics CEO David Lucchino Is Working To Reverse Hearing Loss

Frequency Therapeutics
Frequency Therapeutics
$150,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

C4 Therapeutics Raises $170M in Funding

C4 Therapeutics
C4 Therapeutics
$30,000,000 Venture capital (Series A)
FinSMEs , Xconomy

Regenacy Pharmaceuticals Secures $30M in Series A Financing

Regenacy Pharmaceuticals
Regenacy Pharmaceuticals
Xconomy

Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds

Frequency
Frequency
Frequency Therapeutics
Frequency Therapeutics
$42,000,000 Venture capital (Series B)
PE HUB , FinSMEs

Frequency Therapeutics scores $42 mln Series B

Frequency Therapeutics
Frequency Therapeutics
$32,000,000 Venture capital (Series A)
PE HUB

Frequency Therapeutics takes in $32 mln Series A

Funding Messaging
Frequency
Frequency
Frequency Therapeutics
Frequency Therapeutics
$73,000,000 Venture capital (Series A)
FinSMEs

C4 Therapeutics Closes $73M Series A Financing

Science Health Funding